SLAMF8 Antikörper (C-Term)
Kurzübersicht für SLAMF8 Antikörper (C-Term) (ABIN7836201)
Target
Alle SLAMF8 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Verwendungszweck
- Rabbit polyclonal antibody to CD353
-
Spezifität
- Recognizes endogenous levels of CD353 protein.
-
Aufreinigung
- The antibody was purified by immunogen affinity chromatography.
-
Immunogen
- KLH-conjugated synthetic peptide encompassing a sequence within the C-terminal region of human CD353. The exact sequence is proprietary.
-
-
-
-
Applikationshinweise
- WB (1/500 - 1/1000)
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Liquid in 0.42 % Potassium phosphate, 0.87 % Sodium chloride, pH 7.3, 30 % glycerol, and 0.01 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Shipped at 4°C. Upon delivery aliquot and store at -20°C for one year. Avoid freeze/thaw cycles.
-
-
- SLAMF8 (SLAM Family Member 8 (SLAMF8))
-
Andere Bezeichnung
- SLAMF8
-
Hintergrund
- BLAME, SLAM family member 8, B-lymphocyte activator macrophage expressed, BCM-like membrane protein, CD353
-
Gen-ID
- 56833
-
UniProt
- Q9P0V8
Target
-